Viewing nowSOPIRAZOLE Tablet 20mg (Esomeprazole Magnesium Trihydrate)
Esomeprazole Magnesium Trihydrate 22.25mg
Tablet · Prescription medication
KMS Pharmaceutical Co., Ltd.

MFDS item code 201907091 · Approved 2019.10.07 · Insurance code 654702020
Treatment of reflux and Zollinger-Ellison syndrome; Helicobacter pylori infection, ulcers, and rebleeding; and gastrointestinal disorders caused by anti-inflammatory drugs
This medication is used for the treatment of gastroesophageal reflux disease, erosive gastroesophageal reflux disease, and maintenance therapy to prevent recurrence in patients with esophagitis. It is also effective for the treatment of duodenal ulcers and peptic ulcers in combination with antibiotics to eradicate Helicobacter pylori. It helps treat and prevent gastrointestinal symptoms due to the use of non-steroidal anti-inflammatory drugs. It is also used in the treatment of Zollinger-Ellison syndrome and is suitable for maintenance therapy to prevent rebleeding after bleeding from gastric or duodenal ulcers. Overall, it is widely used to treat various symptoms and diseases related to gastrointestinal disorders.
This drug should be swallowed with a liquid such as water and should not be chewed or crushed. 1. Adults 1) Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. If esophagitis has not healed or symptoms persist, continue taking the drug for another 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. · Once symptoms have resolved, control subsequent symptoms by administering 20 mg once daily. · In adults, 20 mg may be administered once daily as needed. As-needed administration is not recommended for ongoing symptom control in patients at high risk of developing gastric and duodenal ulcers due to use of nonsteroidal anti-inflammatory drugs. 2) Combination therapy with antibiotics for Helicobacter pylori eradication Administer this drug 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning sensation) associated with use of nonsteroidal anti-inflammatory drugs (nonselective or selective COX-2 inhibitors) - 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Clinical trials lasting longer than 4 weeks have not been conducted. 4) Patients requiring continuous use of nonsteroidal anti-inflammatory drugs - Treatment of gastric ulcers associated with use of nonsteroidal anti-inflammatory drugs: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with use of nonsteroidal anti-inflammatory drugs: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The dose should then be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses greater than 80 mg per day should be divided into 2 doses. 6) Maintenance therapy following induction of prevention of rebleeding due to gastric or duodenal ulcers with intravenous administration Administer 40 mg once daily for 4 weeks following induction of prevention of rebleeding due to gastric or duodenal ulcers with intravenous administration. 4. Renal impairment No dose adjustment is necessary. Use with caution because there is limited experience in patients with severe renal impairment. 5. Hepatic impairment No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this drug should not exceed 20 mg. 6. Elderly patients No dose adjustment is necessary.
2. Adolescents aged 12 years and older 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. If esophagitis has not healed or symptoms persist, continue taking the drug for another 4 weeks. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. · Once symptoms have resolved, control subsequent symptoms by administering 20 mg once daily. · In adults, 20 mg may be administered once daily as needed. As-needed administration is not recommended for ongoing symptom control in patients at high risk of developing gastric and duodenal ulcers due to use of nonsteroidal anti-inflammatory drugs. 3. Pediatric patients under 12 years of age There is no experience with administration of this drug to pediatric patients under 12 years of age.
This medication should not be used in certain patients. For example, individuals who are allergic to this medication or its components, or have had hypersensitivity reactions, should not take it. Also, caution is needed for those allergic to penicillin antibiotics or macrolide antibiotics. This medication may interact with certain antiviral or cardiac-related medications, so if you are taking these medications, you must consult a physician. It is advisable for breastfeeding women not to take this medication. This medication contains yellow pigments, so individuals with allergic reactions to these pigments should use it with caution. Various side effects may occur during use; if unusual symptoms such as headache, dizziness, abdominal pain, diarrhea, rash, muscle pain arise, immediate consultation with medical personnel is necessary. Particularly, if muscle pain or weakness worsens, it could be a serious condition such as rhabdomyolysis, requiring prompt action. If this medication is taken for a long time, regular check-ups are necessary to monitor health status, as the risk of gastrointestinal infections may slightly increase; so if diarrhea persists, inform a physician. Additionally, long-term use may increase the risk of bone fractures, and caution is needed for those at risk of osteoporosis. This medication can interact with other medications, so if you are currently taking any medications, you must inform medical personnel, especially when combined with anticoagulants, antiviral drugs, and antibiotics. The safety of this medication during pregnancy has not been fully confirmed, so if you are pregnant or planning to become pregnant, the decision to use it should be made after consulting a physician. It is safest not to take this medication while breastfeeding. There is no specific antidote in the case of overdose, so if symptoms occur, immediately seek appropriate medical treatment. This medication should be kept out of reach of children, and transferring it to another container is discouraged.
Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reactions, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, mental confusion, depression, aggression, hallucinations, headache, dizziness, paresthesia, drowsiness, dysgeusia, blurry vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, elevated liver enzymes, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, alopecia, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, Riel syndrome, acute generalized exanthematous pustulosis, eosinophilia with systemic symptoms drug reaction, fractures, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal bloating, allergic reactions, back pain, chest pain, sternal pain, facial edema, facial flushing, fatigue, fever, flu-like disorders, generalized edema, leg swelling, lethargy, pain, rigidity, peripheral edema, flushing, hypertension, tachycardia, thyroid nodules, irritable bowel syndrome, constipation exacerbation, dyspepsia, dysphagia, gastrointestinal malformation, upper abdominal pain, belching, esophageal disorders, frequent bowel movements, gastroenteritis, gastrointestinal bleeding, hiccups, melena, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, elevated serum gastrin, lingual disorders, swelling of the tongue, ulcerative stomatitis, vomiting, earache, tinnitus, anemia, hypopigmented anemia, cervical lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver dysfunction, elevated ALT, elevated AST, diabetes, hyperuricemia, elevated ALP, dry mouth, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, seizures, fibromyalgia syndrome, hernia, rheumatoid polymyalgia, arthralgia, anorexia, apathy, increased appetite, confusion, worsening depression, myotonia, anxiety, sensory impairment, erectile dysfunction, insomnia, migraine, exacerbation of migraine, sleep disorders, tremors, dizziness, visual field loss, paresthesia, drowsiness, dysmenorrhea, menstrual disorders, vaginitis, exacerbation of asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, rash, erythematous rash, papular rash, angioedema, dermatitis, itching, urticaria, increased sweating, otitis media, abnormal olfaction, loss of taste, taste distortion, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infections, hematuria, urinary frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcers, esophageal varices, gastric ulcers, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, gastric fundic gland polyps, hypocalcemia, hypokalemia, rhabdomyolysis
Not everyone experiences these, and they can vary from person to person.
This medication is easily affected by air or moisture, so it must be stored in a tightly closed container. Additionally, it is best to store the medication at room temperature between 1°C and 30°C. It is safe to avoid extremely hot or cold places.
Pale pink round film-coated tablet
Domestic - 28 tablets/PPT [28 tablets (14 tablets/Alu-Alu×2)], Domestic - 28 tablets/PPT [28 tablets (7 tablets/Alu-Alu×4)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEsomeprazole Magnesium Trihydrate 22.25mg
Tablet · Prescription medication
KMS Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.